Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in Mouse Brain

Ira E. Goldberg, Grace C. Rossi, Sharon R. Letchworth, John P. Mathis, Jennifer Ryan-Moro, Liza Leventhal, Wendy Su, David Emmel, Elizabeth A. Bolan and Gavril W. Pasternak
Journal of Pharmacology and Experimental Therapeutics August 1998, 286 (2) 1007-1013;
Ira E. Goldberg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Grace C. Rossi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sharon R. Letchworth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John P. Mathis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Ryan-Moro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liza Leventhal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wendy Su
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Emmel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Bolan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavril W. Pasternak
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The recently isolated peptides endomorphin-1 and endomorphin-2 have been suggested to be the endogenous ligands for the mureceptor. In traditional opioid receptor binding assays in mouse brain homogenates, both endomorphin-1 and endomorphin-2 competed bothmu1 and mu2receptor sites quite potently. Neither compound had appreciable affinity for either delta orkappa1 receptors, confirming an earlier report. However, the two endomorphins displayed reasonable affinities for kappa3 binding sites, withKi values between 20 and 30 nM. Both endomorphins competed3H-[d-Ala2,MePhe4,Gly(ol)5] enkephalin binding to MOR-1 receptors expressed in CHO cells with high affinity. In mouse brain homogenates 125I-endomorphin-1 and125I-endomorphin-2 binding was selectively competed by mu ligands. 125I-Endomorphin-1 and125I-endomorphin-2 also labeled MOR-1 receptors expressed in CHO cells with high affinity. Autoradiography of the two125I-labeled endomorphins demonstrated regional patterns in the brain similar to those previously observed for mudrugs. Pharmacologically, the endomorphins were potent analgesics. Although they were equipotent supraspinally, endomorphin-1 was more potent spinally. Endomorphin analgesia was effectively blocked by naloxone, as well as the mu-selective antagonists β-funaltrexamine and naloxonazine. In CXBK mice, which are insensitive to supraspinal morphine, neither endomorphin was active, consistent with a mu mechanism of action. Finally, the endomorphins inhibited gastrointestinal transit. In conclusion, these results support the mu selectivity of these agents.

Footnotes

  • Send reprint requests to: Dr. Gavril W. Pasternak, Department of Neurology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021.

  • ↵1 This work was supported, in part, by grants DA02615 and DA07242 from the National Institute on Drug Abuse to G.W.P. and a core grant from the National Cancer Institute to Memorial Sloan-Kettering Cancer Center. G.C.R. was supported by Mentored Scientist Award DA00310, G.W.P. was supported by Research Scientist Award DA00220 from the National Institute on Drug Abuse and S.L. was supported by Training Grant CA09461 from the National Cancer Institute.

  • Abbreviations:
    β-FNA
    β-funaltrexamine
    i.c.v.
    intracerebroventricularly
    MeONtx
    3-methoxynaltrexone
    CHO
    Chinese hamster ovary
    TFA
    trifluoroacetic acid
    DAMGO
    [d-Ala2, MePhe4, Gly (01)5]enkephalin
    • Received January 21, 1998.
    • Accepted April 13, 1998.
  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 286, Issue 2
1 Aug 1998
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in Mouse Brain
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in Mouse Brain

Ira E. Goldberg, Grace C. Rossi, Sharon R. Letchworth, John P. Mathis, Jennifer Ryan-Moro, Liza Leventhal, Wendy Su, David Emmel, Elizabeth A. Bolan and Gavril W. Pasternak
Journal of Pharmacology and Experimental Therapeutics August 1, 1998, 286 (2) 1007-1013;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Pharmacological characterization of Endomorphin-1 and Endomorphin-2 in Mouse Brain

Ira E. Goldberg, Grace C. Rossi, Sharon R. Letchworth, John P. Mathis, Jennifer Ryan-Moro, Liza Leventhal, Wendy Su, David Emmel, Elizabeth A. Bolan and Gavril W. Pasternak
Journal of Pharmacology and Experimental Therapeutics August 1, 1998, 286 (2) 1007-1013;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Interaction of Diclofenac and Quinidine in Monkeys: Stimulation of Diclofenac Metabolism
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics